[1]
N. Kandula, “Characterizing Adverse Effects and Risk Factors in Multidrug Tuberculosis Regimens: Implications for Personalized Treatment Protocols”, 5.8, vol. 1, no. 2, pp. 1-8, Aug. 2023.